The top three pathways we observed were chronic myeloid leukemia signaling, p53 signaling, and hepatocyte growth factor (HGF) signaling, and CDKN2A and PIK3R3 were common molecules involved in these three pathways (Table 6). This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.